Enter assignee name

% Expired Patents = 36.4

CIPO Patents = 3

EPO Patents = 5

Trademarks = 1

Forward Citations = 6

Loading Chart...

6 inventors (with patents filed for the assignee):

Theodore E Maione (7 out of 7 patents)

Constantine Basil Maglaris (6 out of 6 patents)

Chih-Chang Chu (4 out of 34 patents)

4. Daqing Wu (4 out of 5 patents)

5. Joseph Carozza (4 out of 4 patents)

6. James Hamsher (2 out of 2 patents)

7. Dean C Maglaris (0 patent)

11 patents: Sort by Forward Citations

1. 12146002 - Polymer agonists of mu opioid receptors (2024-11-19),

2. 12037416 - Polymer agonists of mu opioid receptors (2024-07-16),

3. 11603385 - Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof (2023-03-14),

4. 11324798 - Materials and methods for treatment of inflammation (2022-05-10),

5. 10975121 - Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof (2021-04-13),

6. 10441625 - Materials and methods for treatment of inflammation (2019-10-15),

7. 8940704 - Advantageous salts of μ-opiate receptor peptides (2015-01-27),

8. 8246994 - Method for delivering an active agent using a hydrogel composition (2012-08-21),

9. 8246993 - Advantageous hydrogel composition (2012-08-21),

10. 8092835 - Injectable microspheres (2012-01-10),

11. 8034383 - Injectable microspheres (2011-10-11),

Cytogel Pharma, LLC is a biopharmaceutical company based in Darien, Connecticut, specializing in the development of innovative therapies for neurological and psychiatric disorders. The organization focuses on advancing its proprietary drug delivery technologies and formulations to enhance treatment efficacy and patient outcomes. With a commitment to addressing unmet medical needs, Cytogel Pharma leverages its expertise in pharmacology and neuroscience to create novel solutions aimed at improving the quality of life for patients suffering from complex conditions.

Profile summary based on public USPTO records.